Permissive cytomegalovirus infection of primary villous term and first trimester trophoblasts.
Forty percent of women with primary cytomegalovirus (CMV) infections during pregnancy infect their fetuses with complications for the baby varying from mild to severe. How CMV crosses the syncytiotrophoblast, the barrier between maternal blood and fetal tissue in the villous placenta, is unknown. Virus may cross by infection of maternal cells that pass through physical breaches in the syncytiotrophoblast or by direct infection of the syncytiotrophoblast, with subsequent transmission to underlying fetal placental cells. In this study, we show that pure (>99.99%), long-term and healthy (>3 weeks) cultures of syncytiotrophoblasts are permissively infected with CMV. Greater than 99% of infectious progeny virus remained cell associated throughout culture periods up to 3 weeks. Infection of term trophoblasts required a higher virus inoculum, was less efficient, and progressed more slowly than parallel infections of placental and human embryonic lung fibroblasts. Three laboratory strains (AD169, Towne, and Davis) and a clinical isolate from a congenitally infected infant all permissively infected trophoblasts, although infection efficiencies varied. The infection of first trimester syncytiotrophoblasts with strain AD169 occurred at higher frequency and progressed more rapidly than infection of term cells but less efficiently and rapidly than infection of fibroblasts. These results show that villous syncytiotrophoblasts can be permissively infected by CMV but that the infection requires high virus titers and proceeds slowly and that progeny virus remains predominantly cell associated.
Hemmings
D G
DG
Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada T6G 2H7.
Kilani
R
R
Nykiforuk
C
C
Preiksaitis
J
J
Guilbert
L J
LJ
D002478:Cells, Cultured; D002824:Chorionic Villi / Q000821:virology*; D003587:Cytomegalovirus / Q000472:pathogenicity; D003586:Cytomegalovirus Infections; D005260:Female; D005347:Fibroblasts / Q000821:virology; D006801:Humans; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D014327:Trophoblasts / Q000821:virology*; D014774:Virulence